{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T16:06:09Z","timestamp":1791302769375,"version":"4.1.0"},"reference-count":89,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2015,4,1]],"date-time":"2015-04-01T00:00:00Z","timestamp":1427846400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100010288","name":"Foundation for the Development of Internal Medicine in Europe (FDIME)","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100010288","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Autoimmunity Reviews"],"published-print":{"date-parts":[[2015,4]]},"DOI":"10.1016\/j.autrev.2014.12.001","type":"journal-article","created":{"date-parts":[[2014,12,6]],"date-time":"2014-12-06T22:17:38Z","timestamp":1417904258000},"page":"314-322","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":67,"title":["Vascular biomarkers and correlation with peripheral vasculopathy in systemic sclerosis"],"prefix":"10.1016","volume":"14","author":[{"given":"In\u00eas","family":"Chora","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Serena","family":"Guiducci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mirko","family":"Manetti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eloisa","family":"Romano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Celestina","family":"Mazzotta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvia","family":"Bellando-Randone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lidia","family":"Ibba-Manneschi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Matucci-Cerinic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raquel","family":"Soares","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.autrev.2014.12.001_bb0005","doi-asserted-by":"crossref","first-page":"133","DOI":"10.2217\/bmm.09.79","article-title":"Biomarkers in systemic sclerosis","volume":"4","author":"Castro","year":"2010","journal-title":"Biomark Med"},{"issue":"1","key":"10.1016\/j.autrev.2014.12.001_bb0010","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1002\/art.37712","article-title":"Differential expression of junctional adhesion molecules in different stages of systemic sclerosis","volume":"65","author":"Manetti","year":"2013","journal-title":"Arthritis Rheum"},{"issue":"6","key":"10.1016\/j.autrev.2014.12.001_bb0015","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.1136\/annrheumdis-2011-200837","article-title":"Increased serum levels and tissue expression of matrix metalloproteinase-12 in patients with systemic sclerosis: correlation with severity of skin and pulmonary fibrosis and vascular damage","volume":"71","author":"Manetti","year":"2012","journal-title":"Ann Rheum Dis"},{"issue":"3","key":"10.1016\/j.autrev.2014.12.001_bb0020","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1186\/ar4230","article-title":"Scleroderma pathogenesis: a pivotal role for fibroblasts as effector cells","volume":"15","author":"Gilbane","year":"2013","journal-title":"Arthritis Res Ther"},{"issue":"11","key":"10.1016\/j.autrev.2014.12.001_bb0025","doi-asserted-by":"crossref","first-page":"2108","DOI":"10.1093\/rheumatology\/ker297","article-title":"Clinical significance of serum levels of sCD36 in patients with systemic sclerosis: preliminary data","volume":"50","author":"Bassyouni","year":"2011","journal-title":"Rheumatology (Oxford)"},{"issue":"8","key":"10.1016\/j.autrev.2014.12.001_bb0030","doi-asserted-by":"crossref","first-page":"1953","DOI":"10.1002\/art.37988","article-title":"Review: Evidence that systemic sclerosis is a vascular disease","volume":"65","author":"Matucci-Cerinic","year":"2013","journal-title":"Arthritis Rheum"},{"issue":"12","key":"10.1016\/j.autrev.2014.12.001_bb0035","doi-asserted-by":"crossref","first-page":"3902","DOI":"10.1002\/art.24038","article-title":"Autoantibodies and microvascular damage are independent predictive factors for the progression of Raynaud's phenomenon to systemic sclerosis: a twenty-year prospective study of 586 patients, with validation of proposed criteria for early systemic sclerosis","volume":"58","author":"Koenig","year":"2008","journal-title":"Arthritis Rheum"},{"issue":"Suppl. 3","key":"10.1016\/j.autrev.2014.12.001_bb0040","first-page":"8","article-title":"The complexity of managing systemic sclerosis: screening and diagnosis","volume":"48","author":"Matucci-Cerinic","year":"2009","journal-title":"Rheumatology (Oxford)"},{"issue":"6A","key":"10.1016\/j.autrev.2014.12.001_bb0045","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1111\/j.1582-4934.2010.01027.x","article-title":"Mechanisms in the loss of capillaries in systemic sclerosis: angiogenesis versus vasculogenesis","volume":"14","author":"Manetti","year":"2010","journal-title":"J Cell Mol Med"},{"issue":"6","key":"10.1016\/j.autrev.2014.12.001_bb0050","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1016\/j.autrev.2013.12.001","article-title":"Raynaud's phenomenon: from molecular pathogenesis to therapy","volume":"13","author":"Prete","year":"2014","journal-title":"Autoimmun Rev"},{"issue":"4","key":"10.1016\/j.autrev.2014.12.001_bb0055","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1111\/j.1365-2133.2009.09567.x","article-title":"Serum levels of soluble vascular endothelial growth factor receptor-2 in patients with systemic sclerosis","volume":"162","author":"Jinnin","year":"2010","journal-title":"Br J Dermatol"},{"issue":"11","key":"10.1016\/j.autrev.2014.12.001_bb0060","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1016\/j.autrev.2013.06.013","article-title":"Systemic sclerosis and cryoglobulinemia: our experience with overlapping syndrome of scleroderma and severe cryoglobulinemic vasculitis and review of the literature","volume":"12","author":"Giuggioli","year":"2013","journal-title":"Autoimmun Rev"},{"issue":"Suppl. 5","key":"10.1016\/j.autrev.2014.12.001_bb0065","doi-asserted-by":"crossref","first-page":"v21","DOI":"10.1093\/rheumatology\/ken281","article-title":"Biomarkers of vascular disease in scleroderma","volume":"47","author":"Hummers","year":"2008","journal-title":"Rheumatology (Oxford)"},{"issue":"10","key":"10.1016\/j.autrev.2014.12.001_bb0070","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1016\/j.autrev.2011.04.019","article-title":"Angiogenic cytokines and growth factors in systemic sclerosis","volume":"10","author":"Liakouli","year":"2011","journal-title":"Autoimmun Rev"},{"issue":"3","key":"10.1016\/j.autrev.2014.12.001_bb0075","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1016\/j.mvr.2010.07.005","article-title":"Capillaroscopic pattern in systemic sclerosis\u2014an association with dynamics of processes of angio- and vasculogenesis","volume":"80","author":"Lambova","year":"2010","journal-title":"Microvasc Res"},{"key":"10.1016\/j.autrev.2014.12.001_bb0080","first-page":"S46","article-title":"Abnormal plasma levels of different angiogenic molecules are associated with different clinical manifestations in patients with systemic sclerosis","volume":"29","author":"Riccieri","year":"2011","journal-title":"Clin. Exp. Rheumatol."},{"issue":"1","key":"10.1016\/j.autrev.2014.12.001_bb0085","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1007\/s11926-011-0219-1","article-title":"Angiogenesis and vasculopathy in systemic sclerosis: evolving concepts","volume":"14","author":"Rabquer","year":"2012","journal-title":"Curr Rheumatol Rep"},{"issue":"6","key":"10.1016\/j.autrev.2014.12.001_bb0090","doi-asserted-by":"crossref","first-page":"R11","DOI":"10.1186\/ar596","article-title":"Angiogenic and angiostatic factors in systemic sclerosis: increased levels of vascular endothelial growth factor are a feature of the earliest disease stages and are associated with the absence of fingertip ulcers","volume":"4","author":"Distler","year":"2002","journal-title":"Arthritis Res"},{"issue":"2","key":"10.1016\/j.autrev.2014.12.001_bb0095","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1002\/art.1780230208","article-title":"Diagnostic potential of in vivo capillary microscopy in scleroderma and related disorders","volume":"23","author":"Maricq","year":"1980","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2014.12.001_bb0100","first-page":"155","article-title":"Nailfold videocapillaroscopy assessment of microvascular damage in systemic sclerosis","volume":"27","author":"Cutolo","year":"2000","journal-title":"J Rheumatol"},{"issue":"11","key":"10.1016\/j.autrev.2014.12.001_bb0105","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1586\/1744666X.2013.849198","article-title":"A systematic overview on the use and relevance of capillaroscopy in systemic sclerosis","volume":"9","author":"Ingegnoli","year":"2013","journal-title":"Expert Rev Clin Immunol"},{"issue":"8","key":"10.1016\/j.autrev.2014.12.001_bb0110","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1016\/j.autrev.2012.11.006","article-title":"The role of nail-videocapillaroscopy in early diagnosis of scleroderma","volume":"12","author":"Rossi","year":"2013","journal-title":"Autoimmun Rev"},{"issue":"4","key":"10.1016\/j.autrev.2014.12.001_bb0115","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1586\/eci.11.35","article-title":"Evaluating microangiopathy in systemic sclerosis: what have we learnt and what is left to discover?","volume":"7","author":"Cutolo","year":"2011","journal-title":"Expert Rev Clin Immunol"},{"issue":"2 Suppl 76","key":"10.1016\/j.autrev.2014.12.001_bb0120","first-page":"103","article-title":"Nailfold capillaroscopy abnormalities as predictors of mortality in patients with systemic sclerosis","volume":"31","author":"Kayser","year":"2013","journal-title":"Clinical Exp Rheumatol"},{"issue":"6","key":"10.1016\/j.autrev.2014.12.001_bb0125","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1007\/s10067-013-2204-8","article-title":"Organ involvement in Argentinian systemic sclerosis patients with \u201clate\u201d pattern as compared to patients with \u201cearly\/active\u201d pattern by nailfold capillaroscopy","volume":"32","author":"Marino Claverie","year":"2013","journal-title":"Clin Rheumatol"},{"key":"10.1016\/j.autrev.2014.12.001_bb0130","article-title":"Digital ulcers as a sentinel sign for early internal organ involvement in very early systemic sclerosis","author":"Bruni","year":"2014","journal-title":"Rheumatology (Oxford)"},{"issue":"12","key":"10.1016\/j.autrev.2014.12.001_bb0135","first-page":"2423","article-title":"Natural history of ischemic digital ulcers in systemic sclerosis: single-center retrospective longitudinal study","volume":"34","author":"Hachulla","year":"2007","journal-title":"J Rheumatol"},{"issue":"Suppl. 3","key":"10.1016\/j.autrev.2014.12.001_bb0140","first-page":"19","article-title":"Digital ulcers: overt vascular disease in systemic sclerosis","volume":"48","author":"Steen","year":"2009","journal-title":"Rheumatology (Oxford)"},{"issue":"6","key":"10.1016\/j.autrev.2014.12.001_bb0145","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1136\/ard.2006.062901","article-title":"Clinical risk assessment of organ manifestations in systemic sclerosis: a report from the EULAR Scleroderma Trials And Research group database","volume":"66","author":"Walker","year":"2007","journal-title":"Ann Rheum Dis"},{"issue":"7","key":"10.1016\/j.autrev.2014.12.001_bb0150","doi-asserted-by":"crossref","first-page":"1374","DOI":"10.1093\/rheumatology\/keq097","article-title":"Digital ulcers in scleroderma: staging, characteristics and sub-setting through observation of 1614 digital lesions","volume":"49","author":"Amanzi","year":"2010","journal-title":"Rheumatology (Oxford)"},{"issue":"2 Suppl 76","key":"10.1016\/j.autrev.2014.12.001_bb0155","first-page":"71","article-title":"Functional impairment of systemic scleroderma patients with digital ulcerations: results from the DUO Registry","volume":"31","author":"Guillevin","year":"2013","journal-title":"Clin Exp Rheumatol"},{"issue":"3","key":"10.1016\/j.autrev.2014.12.001_bb0160","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1136\/annrheumdis-2011-200143","article-title":"Angiogenic biomarkers predict the occurrence of digital ulcers in systemic sclerosis","volume":"71","author":"Avouac","year":"2012","journal-title":"Ann Rheum Dis"},{"issue":"Suppl. 2","key":"10.1016\/j.autrev.2014.12.001_bb0165","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1186\/ar2187","article-title":"Vasculopathy and disordered angiogenesis in selected rheumatic diseases: rheumatoid arthritis and systemic sclerosis","volume":"9","author":"Koch","year":"2007","journal-title":"Arthritis Res Ther"},{"issue":"2","key":"10.1016\/j.autrev.2014.12.001_bb0170","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1007\/s10067-004-0987-3","article-title":"Soluble adhesion molecules (sVCAM-1, sE-selectin), vascular endothelial growth factor (VEGF) and endothelin-1 in patients with systemic sclerosis: relationship to organ systemic involvement","volume":"24","author":"Kuryliszyn-Moskal","year":"2005","journal-title":"Clin Rheumatol"},{"issue":"1","key":"10.1016\/j.autrev.2014.12.001_bb0175","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1006\/clin.1993.1100","article-title":"Circulating intercellular adhesion molecule-1 in patients with systemic sclerosis","volume":"68","author":"Sfikakis","year":"1993","journal-title":"Clin Immunol Immunopathol"},{"issue":"2","key":"10.1016\/j.autrev.2014.12.001_bb0180","doi-asserted-by":"crossref","first-page":"R55","DOI":"10.1186\/ar4217","article-title":"Correlations between angiogenic factors and capillaroscopic patterns in systemic sclerosis","volume":"15","author":"Avouac","year":"2013","journal-title":"Arthritis Res Ther"},{"issue":"9","key":"10.1016\/j.autrev.2014.12.001_bb0185","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1590\/S0100-879X2004000900018","article-title":"Correlation between serum E-selectin levels and panoramic nailfold capillaroscopy in systemic sclerosis","volume":"37","author":"Valim","year":"2004","journal-title":"Braz J Med Biol Res"},{"issue":"3","key":"10.1016\/j.autrev.2014.12.001_bb0190","doi-asserted-by":"crossref","first-page":"R63","DOI":"10.1186\/ar4236","article-title":"Early systemic sclerosis: marker autoantibodies and videocapillaroscopy patterns are each associated with distinct clinical, functional and cellular activation markers","volume":"15","author":"Valentini","year":"2013","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.autrev.2014.12.001_bb0195","doi-asserted-by":"crossref","first-page":"3637","DOI":"10.2741\/2955","article-title":"The roles of chemokines in leukocyte recruitment and fibrosis in systemic sclerosis","volume":"13","author":"Hasegawa","year":"2008","journal-title":"Front Biosci"},{"issue":"Suppl. 71","key":"10.1016\/j.autrev.2014.12.001_bb0200","first-page":"S44","article-title":"CCL2, CCL3 and CCL5 chemokines in systemic sclerosis: the correlation with SSc clinical features and the effect of prostaglandin E1 treatment","volume":"30","author":"Bandinelli","year":"2012","journal-title":"Clin Exp Rheumatol"},{"issue":"2","key":"10.1016\/j.autrev.2014.12.001_bb0205","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1093\/rheumatology\/ken401","article-title":"Monocyte chemoattractant proteins in the pathogenesis of systemic sclerosis","volume":"48","author":"Distler","year":"2009","journal-title":"Rheumatology (Oxford)"},{"issue":"1","key":"10.1016\/j.autrev.2014.12.001_bb0210","doi-asserted-by":"crossref","first-page":"R18","DOI":"10.1186\/ar3242","article-title":"Dysregulated expression of MIG\/CXCL9, IP-10\/CXCL10 and CXCL16 and their receptors in systemic sclerosis","volume":"13","author":"Rabquer","year":"2011","journal-title":"Arthritis Res Ther"},{"issue":"1","key":"10.1016\/j.autrev.2014.12.001_bb0215","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1093\/rheumatology\/kem313","article-title":"CXCL10 (alpha) and CCL2 (beta) chemokines in systemic sclerosis\u2014a longitudinal study","volume":"47","author":"Antonelli","year":"2008","journal-title":"Rheumatology (Oxford)"},{"issue":"4","key":"10.1016\/j.autrev.2014.12.001_bb0220","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1007\/s00403-013-1431-9","article-title":"Fli1 deficiency contributes to the suppression of endothelial CXCL5 expression in systemic sclerosis","volume":"306","author":"Ichimura","year":"2014","journal-title":"Arch Dermatol Res"},{"issue":"6","key":"10.1016\/j.autrev.2014.12.001_bb0225","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1007\/s10875-014-0037-0","article-title":"Early systemic sclerosis: serum profiling of factors involved in endothelial, T-cell, and fibroblast interplay is marked by elevated interleukin-33 levels","volume":"34","author":"Vettori","year":"2014","journal-title":"J Clin Immunol"},{"issue":"2","key":"10.1016\/j.autrev.2014.12.001_bb0230","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1111\/j.1365-2133.2009.09507.x","article-title":"CCL13 is a promising diagnostic marker for systemic sclerosis","volume":"162","author":"Yanaba","year":"2010","journal-title":"Br J Dermatol"},{"issue":"1","key":"10.1016\/j.autrev.2014.12.001_bb0235","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1111\/j.1365-2133.2011.10330.x","article-title":"Serum CCL13 levels in patients with systemic sclerosis and controls","volume":"165","author":"Gambichler","year":"2011","journal-title":"Br J Dermatol"},{"issue":"1","key":"10.1016\/j.autrev.2014.12.001_bb0240","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1007\/s00403-010-1078-8","article-title":"Serum CCL23 levels are increased in patients with systemic sclerosis","volume":"303","author":"Yanaba","year":"2011","journal-title":"Arch Dermatol Res"},{"issue":"7","key":"10.1016\/j.autrev.2014.12.001_bb0245","first-page":"1529","article-title":"Elevated vascular endothelial growth factor in systemic sclerosis","volume":"30","author":"Choi","year":"2003","journal-title":"J Rheumatol"},{"issue":"4","key":"10.1016\/j.autrev.2014.12.001_bb0250","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1111\/1756-185X.12130","article-title":"Dysregulation of angiogenic homeostasis in systemic sclerosis","volume":"16","author":"Farouk","year":"2013","journal-title":"Int J Rheum Dis"},{"key":"10.1016\/j.autrev.2014.12.001_bb0255","doi-asserted-by":"crossref","first-page":"255","DOI":"10.2478\/v10039-011-0025-z","article-title":"Peripheral blood mononuclear cells from patients with systemic sclerosis spontaneously secrete increased amounts of vascular endothelial growth factor (VEGF) already in the early stage of the disease","volume":"56","author":"Bielecki","year":"2011","journal-title":"Adv Med Sci"},{"issue":"9","key":"10.1016\/j.autrev.2014.12.001_bb0260","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1093\/rheumatology\/kep154","article-title":"The transport of high amounts of vascular endothelial growth factor by blood platelets underlines their potential contribution in systemic sclerosis angiogenesis","volume":"48","author":"Solanilla","year":"2009","journal-title":"Rheumatology (Oxford)"},{"issue":"1","key":"10.1016\/j.autrev.2014.12.001_bb0265","doi-asserted-by":"crossref","first-page":"e86273","DOI":"10.1371\/journal.pone.0086273","article-title":"ENDOGLIN is dispensable for vasculogenesis, but required for vascular endothelial growth factor-induced angiogenesis","volume":"9","author":"Liu","year":"2014","journal-title":"PLoS ONE"},{"issue":"7","key":"10.1016\/j.autrev.2014.12.001_bb0270","doi-asserted-by":"crossref","first-page":"972","DOI":"10.1093\/rheumatology\/ken100","article-title":"Disturbed angiogenesis in systemic sclerosis: high levels of soluble endoglin","volume":"47","author":"Wipff","year":"2008","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.autrev.2014.12.001_bb0275","doi-asserted-by":"crossref","first-page":"125632","DOI":"10.1155\/2013\/125632","article-title":"Endothelin-1 levels in scleroderma patients: a pilot study","volume":"2013","author":"Cozzani","year":"2013","journal-title":"ISRN Dermatol"},{"key":"10.1016\/j.autrev.2014.12.001_bb0280","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.3899\/jrheum.081030","article-title":"Raynaud's phenomenon and plasma endothelin: correlations with capillaroscopic patterns in systemic sclerosis","volume":"36","author":"Sulli","year":"2009","journal-title":"J Rheumatol"},{"issue":"3","key":"10.1016\/j.autrev.2014.12.001_bb0285","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1007\/s10067-009-1288-7","article-title":"Capillary dimension measured by computer-based digitalized image correlated with plasma endothelin-1 levels in patients with systemic sclerosis","volume":"29","author":"Kim","year":"2010","journal-title":"Clin Rheumatol"},{"issue":"2","key":"10.1016\/j.autrev.2014.12.001_bb0290","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1007\/s00296-012-2378-4","article-title":"Circulating angiopoietin and Tie-2 levels in systemic sclerosis","volume":"33","author":"Dunne","year":"2013","journal-title":"Rheumatol Int"},{"issue":"4","key":"10.1016\/j.autrev.2014.12.001_bb0295","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1007\/s00403-012-1307-4","article-title":"Clinical significance of serum soluble Tie1 levels in patients with systemic sclerosis","volume":"305","author":"Noda","year":"2013","journal-title":"Arch Dermatol Res"},{"issue":"4","key":"10.1016\/j.autrev.2014.12.001_bb0300","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1093\/rheumatology\/keq392","article-title":"Angiopoietins-1 and -2 are differentially expressed in the sera of patients with systemic sclerosis: high angiopoietin-2 levels are associated with greater severity and higher activity of the disease","volume":"50","author":"Michalska-Jakubus","year":"2011","journal-title":"Rheumatology (Oxford)"},{"issue":"2","key":"10.1016\/j.autrev.2014.12.001_bb0305","doi-asserted-by":"crossref","first-page":"157","DOI":"10.2340\/00015555-1680","article-title":"Serum angiopoietin-like protein 3 levels: possible correlation with progressive skin sclerosis, digital ulcers and pulmonary vascular involvement in patients with systemic sclerosis","volume":"94","author":"Ichimura","year":"2014","journal-title":"Acta Derm Venereol"},{"issue":"3","key":"10.1016\/j.autrev.2014.12.001_bb0310","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1111\/j.1468-3083.2011.04413.x","article-title":"Clinical significance of serum retinol binding protein-4 levels in patients with systemic sclerosis","volume":"27","author":"Toyama","year":"2013","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"3","key":"10.1016\/j.autrev.2014.12.001_bb0315","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1136\/ard.2004.023382","article-title":"Increased circulating levels of tissue kallikrein in systemic sclerosis correlate with microvascular involvement","volume":"64","author":"Del Rosso","year":"2005","journal-title":"Ann Rheum Dis"},{"issue":"2","key":"10.1016\/j.autrev.2014.12.001_bb0320","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1007\/s10067-002-0684-z","article-title":"Interleukin-13 in systemic sclerosis: relationship to nailfold capillaroscopy abnormalities","volume":"22","author":"Riccieri","year":"2003","journal-title":"Clin Rheumatol"},{"issue":"1","key":"10.1016\/j.autrev.2014.12.001_bb0325","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1136\/annrheumdis-2012-201553","article-title":"Increased serum IL-33 levels may indicate vascular involvement in systemic sclerosis","volume":"72","author":"Terras","year":"2013","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.autrev.2014.12.001_bb0330","doi-asserted-by":"crossref","first-page":"1876","DOI":"10.1136\/ard.2010.148247","article-title":"Increased circulating levels of interleukin 33 in systemic sclerosis correlate with early disease stage and microvascular involvement","volume":"70","author":"Manetti","year":"2011","journal-title":"Ann Rheum Dis"},{"issue":"3","key":"10.1016\/j.autrev.2014.12.001_bb0335","doi-asserted-by":"crossref","first-page":"539","DOI":"10.3899\/jrheum.110755","article-title":"Serum levels of galectin-3: possible association with fibrosis, aberrant angiogenesis, and immune activation in patients with systemic sclerosis","volume":"39","author":"Taniguchi","year":"2012","journal-title":"J Rheumatol"},{"key":"10.1016\/j.autrev.2014.12.001_bb0340","doi-asserted-by":"crossref","DOI":"10.1111\/1756-185X.12288","article-title":"Circulating galectin-1 concentrations in systemic sclerosis: potential contribution to digital vasculopathy","author":"Yanaba","year":"2014","journal-title":"Int J Rheum Dis"},{"issue":"1","key":"10.1016\/j.autrev.2014.12.001_bb0345","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1111\/j.1468-3083.2011.04354.x","article-title":"Serum apelin levels: clinical association with vascular involvements in patients with systemic sclerosis","volume":"27","author":"Aozasa","year":"2013","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"3","key":"10.1016\/j.autrev.2014.12.001_bb0350","doi-asserted-by":"crossref","first-page":"R69","DOI":"10.1186\/ar4246","article-title":"High serum sCD163\/sTWEAK ratio is associated with lower risk of digital ulcers but more severe skin disease in patients with systemic sclerosis","volume":"15","author":"Kowal-Bielecka","year":"2013","journal-title":"Arthritis Res Ther"},{"issue":"3","key":"10.1016\/j.autrev.2014.12.001_bb0355","first-page":"465","article-title":"Diminished production of TWEAK by the peripheral blood mononuclear cells is associated with vascular involvement in patients with systemic sclerosis","volume":"47","author":"Bielecki","year":"2009","journal-title":"Folia Histochem Cytobiol"},{"issue":"3","key":"10.1016\/j.autrev.2014.12.001_bb0360","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1684\/ejd.2012.1702","article-title":"Clinical significance of serum decoy receptor 3 levels in patients with systemic sclerosis","volume":"22","author":"Yamada","year":"2012","journal-title":"Eur J Dermatol"},{"issue":"4","key":"10.1016\/j.autrev.2014.12.001_bb0365","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1002\/1529-0131(200004)43:4<889::AID-ANR21>3.0.CO;2-5","article-title":"Increased concentrations of the circulating angiogenesis inhibitor endostatin in patients with systemic sclerosis","volume":"43","author":"Hebbar","year":"2000","journal-title":"Arthritis & Rheumatism"},{"issue":"3","key":"10.1016\/j.autrev.2014.12.001_bb0370","doi-asserted-by":"crossref","first-page":"e14","DOI":"10.1161\/CIRCRESAHA.111.242057","article-title":"Overexpression of VEGF165b, an inhibitory splice variant of vascular endothelial growth factor, leads to insufficient angiogenesis in patients with systemic sclerosis","volume":"109","author":"Manetti","year":"2011","journal-title":"Circ Res"},{"issue":"7","key":"10.1016\/j.autrev.2014.12.001_bb0375","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1016\/j.tcm.2012.05.011","article-title":"Impaired angiogenesis in systemic sclerosis: the emerging role of the antiangiogenic VEGF(165)b splice variant","volume":"21","author":"Manetti","year":"2011","journal-title":"Trends Cardiovasc Med"},{"issue":"8","key":"10.1016\/j.autrev.2014.12.001_bb0380","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.1136\/annrheumdis-2012-203183","article-title":"Increased plasma levels of the VEGF165b splice variant are associated with the severity of nailfold capillary loss in systemic sclerosis","volume":"72","author":"Manetti","year":"2013","journal-title":"Ann Rheum Dis"},{"issue":"10","key":"10.1016\/j.autrev.2014.12.001_bb0385","doi-asserted-by":"crossref","first-page":"3275","DOI":"10.1002\/art.20562","article-title":"Matrix metalloproteinase 12-dependent cleavage of urokinase receptor in systemic sclerosis microvascular endothelial cells results in impaired angiogenesis","volume":"50","author":"D'Alessio","year":"2004","journal-title":"Arthritis Rheum"},{"issue":"3","key":"10.1016\/j.autrev.2014.12.001_bb0390","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1016\/j.autrev.2012.05.011","article-title":"Autoantibodies in systemic sclerosis","volume":"12","author":"Mehra","year":"2013","journal-title":"Autoimmun Rev"},{"issue":"2","key":"10.1016\/j.autrev.2014.12.001_bb0395","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.autrev.2012.07.005","article-title":"Diagnostic accuracy and predictive value of extended autoantibody profile in systemic sclerosis","volume":"12","author":"Villalta","year":"2012","journal-title":"Autoimmun Rev"},{"issue":"10","key":"10.1016\/j.autrev.2014.12.001_bb0400","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1016\/j.autrev.2011.04.016","article-title":"Cellular players in angiogenesis during the course of systemic sclerosis","volume":"10","author":"Cipriani","year":"2011","journal-title":"Autoimmun Rev"},{"issue":"Suppl. 6","key":"10.1016\/j.autrev.2014.12.001_bb0405","first-page":"791","article-title":"Angiogenic activity of sera from patients with systemic autoimmune diseases in relation to clinical, radiological and functional pulmonary status","volume":"59","author":"Zielonka","year":"2008","journal-title":"J Physiol Pharmacol"},{"key":"10.1016\/j.autrev.2014.12.001_bb0410","first-page":"992","article-title":"More severe nailfold capillaroscopy findings and anti-endothelial cell antibodies. Are they useful tools for prognostic use in systemic sclerosis?","volume":"26","author":"Riccieri","year":"2008","journal-title":"Clin Exp Rheumatol"},{"issue":"3","key":"10.1016\/j.autrev.2014.12.001_bb0415","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1136\/ard.2010.135772","article-title":"Involvement of functional autoantibodies against vascular receptors in systemic sclerosis","volume":"70","author":"Riemekasten","year":"2011","journal-title":"Ann Rheum Dis"},{"issue":"9","key":"10.1016\/j.autrev.2014.12.001_bb0420","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1016\/j.autrev.2011.04.007","article-title":"Anti-annexins autoantibodies: their role as biomarkers of autoimmune diseases","volume":"10","author":"Iaccarino","year":"2011","journal-title":"Autoimmun Rev"},{"issue":"1","key":"10.1016\/j.autrev.2014.12.001_bb0425","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.autrev.2004.07.006","article-title":"Anti-annexin V antibodies: are they prothrombotic?","volume":"4","author":"Esposito","year":"2005","journal-title":"Autoimmun Rev"},{"issue":"10","key":"10.1016\/j.autrev.2014.12.001_bb0430","first-page":"2168","article-title":"Anti-annexin V antibodies and digital ischemia in patients with scleroderma","volume":"26","author":"Sugiura","year":"1999","journal-title":"J Rheumatol"},{"issue":"1","key":"10.1016\/j.autrev.2014.12.001_bb0435","first-page":"1","article-title":"Clinical significance of serum anti-annexin V antibodies in Egyptian patients with scleroderma","volume":"16","author":"El Serougy","year":"2009","journal-title":"Egypt J Immunol"},{"key":"10.1016\/j.autrev.2014.12.001_bb0440","doi-asserted-by":"crossref","first-page":"15","DOI":"10.4137\/CMAMD.S4503","article-title":"Anti-annexin v antibodies: association with vascular involvement and disease outcome in patients with systemic sclerosis","volume":"3","author":"Habeeb","year":"2010","journal-title":"Clin Med Insights Arthritis Musculoskelet Disord"},{"issue":"1","key":"10.1016\/j.autrev.2014.12.001_bb0445","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1024\/0301-1526\/a000065","article-title":"Systemic sclerosis\u2014a systematic overview: part 1\u2014disease characteristics and classification, pathophysiologic concepts, and recommendations for diagnosis and surveillance","volume":"40","author":"Klein-Weigel","year":"2011","journal-title":"Vasa"}],"container-title":["Autoimmunity Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1568997214002870?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1568997214002870?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,8,27]],"date-time":"2020-08-27T16:35:13Z","timestamp":1598546113000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1568997214002870"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,4]]},"references-count":89,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2015,4]]}},"alternative-id":["S1568997214002870"],"URL":"https:\/\/doi.org\/10.1016\/j.autrev.2014.12.001","relation":{},"ISSN":["1568-9972"],"issn-type":[{"value":"1568-9972","type":"print"}],"subject":[],"published":{"date-parts":[[2015,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Vascular biomarkers and correlation with peripheral vasculopathy in systemic sclerosis","name":"articletitle","label":"Article Title"},{"value":"Autoimmunity Reviews","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.autrev.2014.12.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}